SCHEMBL6891238

SCHEMBL6891238

CCN1CCC(N)(c2ccc(C)cn2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
NOS3 P29474 1/20 0.34
NOS2 P35228 1/20 0.34
OPRM1 P35372 2/20 0.34
OPRD1 P41143 2/20 0.34
OPRK1 P41145 2/20 0.34
TP53 P04637 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
KDM4E B2RXH2 1/20 0.33
KDM2B Q8NHM5 1/20 0.33
PTPN11 Q06124 1/20 0.33
SYK P43405 1/20 0.33
DHFR P00374 1/20 0.33
ADRA2A P08913 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2392188 0.82 NOS3 (0.45) NOS3NOS2OPRM1HRH3MAPT
SCHEMBL16545978 0.79 NOS3 (0.42) NOS3NOS2HRH3MAPTSYK
SCHEMBL6888922 0.78 ADRA1A (0.41) ALDH1A1OPRM1OPRD1TP53HRH3
SCHEMBL6888271 0.78 CCR1 (0.42) ALDH1A1MEN1KMT2ANOS3NOS2
SCHEMBL6887840 0.77 GRIN1 (0.42) KMT2AOPRM1OPRD1OPRK1LMNA
SCHEMBL7617880 0.71 ALDH1A1 (0.56) ALDH1A1MEN1KMT2ATP53HRH3
SCHEMBL16546000 0.70 NOS3 (0.41) NOS3NOS2OPRM1HRH3MAPT
Hydrochloric Acid SCHEMBL15228237 0.68 NOS3 (0.38) NOS3NOS2OPRM1MAPTADRA2A
SCHEMBL14376090 0.68 KDM4E (0.56) ALDH1A1MEN1KMT2ATP53HRH3
SCHEMBL6888869 0.67 OPRM1 (0.53) OPRM1OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120232076-A1 QUINOLIZIDINONE CARBOXAMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS MERCK SHARP & DOHME LLC 2012-09-13 US disclosed
WO-2011062853-A1 QUINOLIZIDINONE CARBOXAMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS MERCK SHARP & DOHME CORP. (US) 2011-05-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120232076-A1 QUINOLIZIDINONE CARBOXAMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS CHRM1, CHRM2, CHRM4 ALDH1A1 2121/4885MEN1 3404/4885KMT2A 1145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.